Skip to main content
. Author manuscript; available in PMC: 2015 Jan 16.
Published in final edited form as: Stat Med. 2014 May 20;33(24):4170–4185. doi: 10.1002/sim.6197

Figure 7.

Figure 7

Enhanced tipping-point displays for the next four adverse events from the clinical trial described in Section 5. Again, all models lead to the same conclusion of no difference in rates of adverse events between the treatment group and the control group.